120 related articles for article (PubMed ID: 32654200)
21. Comparison between bone marrow and G-CSF-mobilized peripheral blood allografts undergoing clinical scale CD34+ cell selection.
Hassan HT; Zeller W; Stockschläder M; Krüger W; Hoffknecht MM; Zander AR
Stem Cells; 1996 Jul; 14(4):419-29. PubMed ID: 8843543
[TBL] [Abstract][Full Text] [Related]
22. Semiautomated autologous bone marrow processing for transplantation.
Pierelli L; Menichella G; Paoloni A; Serafini R; Vittori M; Foddai ML; Meoni F; Rossi PL; Leone G; Mango G
Haematologica; 1991 Mar; 76 Suppl 1():10-1. PubMed ID: 1677909
[TBL] [Abstract][Full Text] [Related]
23. Hematopoietic stem cell transplantation in Europe 1998.
Gratwohl A; Passweg J; Baldomero H; Hermans J; Urbano-Ispizua A;
Hematol J; 2000; 1(5):333-50. PubMed ID: 11920211
[TBL] [Abstract][Full Text] [Related]
24. Studies on the mechanism of tolerance or graft-versus-host disease in allogeneic bone marrow recipients at the level of cytotoxic T-cell precursor frequencies.
Irschick EU; Hladik F; Niederwieser D; Nussbaumer W; Holler E; Kaminski E; Huber C
Blood; 1992 Mar; 79(6):1622-8. PubMed ID: 1547351
[TBL] [Abstract][Full Text] [Related]
25. Allogeneic hematopoietic stem cells from sources other than bone marrow: biological and technical aspects.
Bertolini F; de Vincentiis A; Lanata L; Lemoli RM; Maccario R; Majolino I; Ponchio L; Rondelli D; Tabilio A; Zanon P; Tura S
Haematologica; 1997; 82(2):220-38. PubMed ID: 9175330
[TBL] [Abstract][Full Text] [Related]
26. Processing of hematopoietic stem cells from peripheral blood before cryopreservation: use of a closed automated system.
Zinno F; Landi F; Scerpa MC; Aureli V; Lanti A; Ceccarelli S; Caniglia M; Miele MJ; Daniele N; Landolfo A; Cometa AM; Locatelli F; Isacchi G
Transfusion; 2011 Dec; 51(12):2656-63. PubMed ID: 21599671
[TBL] [Abstract][Full Text] [Related]
27. Pre-clinical assessment of the Lovo device for dimethyl sulfoxide removal and cell concentration in thawed hematopoietic progenitor cell grafts.
Mfarrej B; Bouchet G; Couquiaud J; Regimbaud L; Binninger S; Mercier M; Lemarié C; Houzé P; Chabannon C; Calmels B
Cytotherapy; 2017 Dec; 19(12):1501-1508. PubMed ID: 29037941
[TBL] [Abstract][Full Text] [Related]
28. Hematopoietic cell infusion-related adverse events in pediatric/small recipients in a prospective/multicenter study.
Ikeda K; Ohto H; Yamada-Fujiwara M; Okuyama Y; Fujiwara SI; Muroi K; Mori T; Kasama K; Kanamori H; Iseki T; Nagamura-Inoue T; Kameda K; Kanda J; Nagai K; Fujii N; Ashida T; Hirose A; Takahashi T; Minakawa K; Tanosaki R
Transfusion; 2020 May; 60(5):1015-1023. PubMed ID: 32306410
[TBL] [Abstract][Full Text] [Related]
29. A study to compare Hematopoietic Progenitor Cell count determined on a next-generation automated cell counter with flow cytometric CD34 count in peripheral blood and the harvested peripheral blood stem cell graft from autologous and allogenic donors.
Mishra S; Kulkarni U; Mathews N; V R; Ch Nair S; George B; Mammen JJ
Int J Lab Hematol; 2021 Feb; 43(1):76-83. PubMed ID: 32926561
[TBL] [Abstract][Full Text] [Related]
30. Network geometry of evidence from randomised controlled trials addressing donor selection and source of haematopoietic progenitor cells used in allogeneic transplantation: a systematic scoping review.
Monaghan M; Rizk M; Pilon S; Iyengar A; Shorr R; Tay J; Maze D; Bredeson C; Hutton B; Allan DS
Transfus Med; 2018 Oct; 28(5):371-379. PubMed ID: 29380924
[TBL] [Abstract][Full Text] [Related]
31. FAHCT accreditation: common deficiencies during on-site inspections.
Warkentin PI; Nick L; Shpall EJ
Cytotherapy; 2000; 2(3):213-20. PubMed ID: 12042044
[TBL] [Abstract][Full Text] [Related]
32. Variations in novel cellular therapy products manufacturing.
Fontaine MJ; Selogie E; Stroncek D; McKenna D; Szczepiorkowski ZM; Takanashi M; Garritsen H; Girdlestone J; Reems JA;
Cytotherapy; 2020 Jun; 22(6):337-342. PubMed ID: 32223996
[TBL] [Abstract][Full Text] [Related]
33. Hematopoietic stem cell transplantation in the Eastern Mediterranean Region (EMRO) 2011-2012: A comprehensive report on behalf of the Eastern Mediterranean Blood and Marrow Transplantation group (EMBMT).
Aljurf M; Nassar A; Hamidieh AA; Elhaddad A; Hamladji RM; Bazarbachi A; Ibrahim A; Ben Othman T; Abdel-Rahman F; Alseraihy A; Fahmy O; Hussein AA; Alabdulaaly A; Adil S; Alkindi SS; Bayoumy M; Dennison D; Bekadja MA; Redhouane AN; Rasheed W; AlSagheir A; Alsudairy R; Ladeb S; Benchekroun S; Ramzi M; Ahmed P; ElSolh H; Ahmed SO; Hussain F; Ghavamzadeh A
Hematol Oncol Stem Cell Ther; 2015 Dec; 8(4):167-75. PubMed ID: 26452331
[TBL] [Abstract][Full Text] [Related]
34. Microbial contamination of peripheral blood and bone marrow hematopoietic cell products and environmental contamination in a stem cell bank: a single-center report.
Kozlowska-Skrzypczak M; Bembnista E; Kubiak A; Matuszak P; Schneider A; Komarnicki M
Transplant Proc; 2014 Oct; 46(8):2873-6. PubMed ID: 25380939
[TBL] [Abstract][Full Text] [Related]
35. Long-term effects of cryopreservation on clinically prepared hematopoietic progenitor cell products.
Winter JM; Jacobson P; Bullough B; Christensen AP; Boyer M; Reems JA
Cytotherapy; 2014 Jul; 16(7):965-75. PubMed ID: 24910385
[TBL] [Abstract][Full Text] [Related]
36. [Umbilical cord hematopoietic progenitor cells bank].
Morales VH; Milone J; Etchegoyen O; Bordone J; Uranga A
Medicina (B Aires); 2001; 61(6):843-8. PubMed ID: 11808425
[TBL] [Abstract][Full Text] [Related]
37. Training practices of hematopoietic progenitor cell-apheresis and -cord blood collection staff: analysis of a survey by the Alliance for Harmonisation of Cellular Therapy Accreditation.
Celluzzi CM; Keever-Taylor C; Aljurf M; Koh MB; Rabe F; Rebulla P; Sacchi N; Sanders J; McGrath E; Loper K;
Transfusion; 2014 Dec; 54(12):3138-44. PubMed ID: 24947542
[TBL] [Abstract][Full Text] [Related]
38. Healthcare center-based cell therapy laboratories supporting off-site manufactured cell therapies: The experiences of a single academic cell therapy laboratory.
Dinh A; Stroncek DF
Transfusion; 2024 Feb; 64(2):357-366. PubMed ID: 38173340
[TBL] [Abstract][Full Text] [Related]
39. Diffuse alveolar hemorrhage is most often fatal and is affected by graft source, conditioning regimen toxicity, and engraftment kinetics.
Keklik F; Alrawi EB; Cao Q; Bejanyan N; Rashidi A; Lazaryan A; Arndt P; Dincer EH; Bachanova V; Warlick ED; MacMillan ML; Arora M; Miller J; Brunstein CG; Weisdorf DJ; Ustun C
Haematologica; 2018 Dec; 103(12):2109-2115. PubMed ID: 30076172
[TBL] [Abstract][Full Text] [Related]
40. Effect of Recipient Age and Stem Cell Source on the Association between Donor Telomere Length and Survival after Allogeneic Unrelated Hematopoietic Cell Transplantation for Severe Aplastic Anemia.
Gadalla SM; Wang T; Dagnall C; Haagenson M; Spellman SR; Hicks B; Jones K; Katki HA; Lee SJ; Savage SA
Biol Blood Marrow Transplant; 2016 Dec; 22(12):2276-2282. PubMed ID: 27641680
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
